Norway vs South Sudan: Treatment success rate for patients treated for MDR-TB
Norway
91.0%
in 2022
South Sudan
94.0%
in 2022
Norway rank
21st
South Sudan rank
19th
Treatment success rate for patients treated for MDR-TB over time
- Norway
- South Sudan
How they compare
South Sudan currently reports 94.0% against 91.0% in Norway, a difference of 3.0%.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was Norway ahead.
Norway ranks 21st and South Sudan ranks 19th of 163 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Norway | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 74.0% | 87.7% | 13.7% | South Sudan |
| 2020s | 86.0% | 93.0% | 7.0% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Norway or South Sudan?
- South Sudan, at 94.0% against 91.0% in Norway as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Norway and South Sudan?
- 3.0%, with South Sudan ahead.
- How many years of comparable data are there for Norway and South Sudan?
- 6 years are reported by both, from 2017 to 2022.
- How do Norway and South Sudan rank globally for treatment success rate for patients treated for mdr-tb?
- Norway ranks 21st and South Sudan ranks 19th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.